SNCA

gene product
alpha-synuclein, NACP, PARK1, PARK4, PD1
Alpha-synuclein is a member of the synuclein family, which also includes beta- and gamma-synuclein. Synucleins are abundantly expressed in the brain and alpha- and beta-synuclein inhibit phospholipase D2 selectively. SNCA may serve to integrate presynaptic signaling and membrane trafficking. Defects in SNCA have been implicated in the pathogenesis of Parkinson disease. SNCA peptides are a major component of amyloid plaques in the brains of patients with Alzheimer's disease. Four alternatively spliced transcripts encoding two different isoforms have been identified for this gene. [provided by RefSeq, Mar 2009]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Reference

Provider

Host

Reactivity

Antibody type

  or   Clear
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
820 antibodies from 28 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
antibodies-online
347 antibodies
Novus Biologicals
36 antibodies
Biosensis Pty Ltd
3 antibodies
Abnova Corporation
35 antibodies
Thermo Fisher Scientific Pierce
18 antibodies
GeneTex
25 antibodies
Atlas Antibodies
1 antibody
Proteintech Group
1 antibody
R&D Systems
4 antibodies
Acris Antibodies GmbH
87 antibodies
LifeSpan BioSciences, Inc.
83 antibodies
Signalway Antibody LLC
8 antibodies
Aviva Systems Biology
25 antibodies
Cell Signaling Technology, Inc
8 antibodies
Rockland Immunochemicals, Inc.
1 antibody
Creative Biomart
82 antibodies
RabMAbs
8 antibodies
PhosphoSolutions
2 antibodies
Everest Biotech
2 antibodies
SignalChem
2 antibodies
EMD Millipore
13 antibodies
Enzo Life Sciences
6 antibodies
Spring Bioscience
4 antibodies
Abbiotec
4 antibodies
GenWay
8 antibodies
Sigma-Aldrich
4 antibodies
United States Biological
2 antibodies
Sino Biological Inc.
1 antibody